Daiichi Sankyo CO Ltd

FD4S 
(FSE) 
 

Company Profile

Description
Daiichi Sankyo Co Ltd is a Japanese pharmaceutical company. It focuses on research and development for bringing up forth novel therapies in oncology, including immune oncology, with further focus on new areas, such as pain management, neurodegenerative diseases, heart and kidney diseases. Daiichi, through pharmaceutical technology platform, develops processes for manufacturing of quality pharmaceuticals that meet desired efficacy and safety parameters. Daiichi is involved in process technology, biotechnology, formulation technology, analytical and quality evaluation technology. Its products brand includes PRALIA, MOVANTIK, LIXIANA, levofloxacin, Injectafer and others. The company has its business operations in Europe, North America, and Japan. Most of its revenue comes from Japan.
Key Stats
Website:
Headquarter country:
Employees: 0
Market Cap (at close ):
Fiscal Year Ends:

Stats



Price/Earnings
Forward Price/Earnings
Price/Free Cash Flow
Return of Assets
Return on Equity
Return on Invested Capital
20182017201620152014

Dividend


Dividend/Share
Ex. Dividend Date
Trailing Dividend Yield
Payout Ratio





Date Currency Amount

Income Statement DKK



Revenue
Total Revenue
Gross Profit
Gross Margin %
EBITDA
Net Income
Basic Earnings Per Share

Operating Expenses
Operating Income
Operation Margin %
20182017201620152014


Cash Flow DKK



Operating Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow
20182017201620152014


Balance Sheet DKK



Assets
Current Assets
Long Term Assets
Total Assets

Liabilities
Total Current Liabilities
Long Term Liabilities
Total Liabilities

Equity
Retained Earnings
Treasury Stock
Total Stockholder Equity
Net Tangible Assets
31/12/201831/12/201731/12/201631/12/201531/12/2014



Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 August 2019 09:18:40
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB7 - 2019-08-26 10:18:40 - 2019-08-26 09:18:40 - 1000 - Website: OKAY